Cargando…
Expression of ANGPTL2 and its impact on papillary thyroid cancer
BACKGROUND: Although the most thyroid carcinoma patients have good prognosis, around 20% of papillary thyroid carcinoma (PTC) patients have a high rate of metastasis and recurrence after routine treatment, which causes high lethality with these patients. Tumor proliferation, metastasis, and invasion...
Autores principales: | Yang, Longyan, Sun, Rongxin, Wang, Yan, Fu, Ying, Zhang, Yuanyuan, Zheng, Zhaohui, Ji, Zhili, Zhao, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668118/ https://www.ncbi.nlm.nih.gov/pubmed/31384179 http://dx.doi.org/10.1186/s12935-019-0908-9 |
Ejemplares similares
-
ANGPTL4 Promotes the Proliferation of Papillary Thyroid Cancer via AKT Pathway
por: Yang, Longyan, et al.
Publicado: (2020) -
ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence
por: Sun, Rongxin, et al.
Publicado: (2020) -
SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways
por: Wang, Yan, et al.
Publicado: (2022) -
Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism
por: Yang, Longyan, et al.
Publicado: (2019) -
RRS1 gene expression involved in the progression of papillary thyroid carcinoma
por: Chen, Feng, et al.
Publicado: (2018)